This analysis also revealed that a significant difference between critically ill COVID-19 patients and those with only mild disease was the presence of a population of NK cells with markedly reduced expression of the activating receptor NKG2D (Figure 3C, Supplementary Figure 5A). Here, KLRK1 is linked to COVID-19.